Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world
  • Posted by Julie Denny
  • June 4, 2014
  • Events

EULAR Annual European Congress of Rheumatology 2014

EULAR Annual European Congress of Rheumatology 2014

Join us at EULAR Congress 2014 in Paris on Friday 13th June at 11:45 - 13:30

We are delighted to be attending and presenting at this year’s EULAR Annual European Congress of Rheumatology in Paris. The EULAR annual congress is a major event in the field of rheumatology and a great forum for scientific (both clinical and basic) educational and social exchange between healthcare professionals involved in rheumatology, patient organisations and the pharmaceutical industry. Representing the Research Partnership and more specifically, Therapy Watch, will be Director Allison Fleetwood and Associate Director Laurent Chanroux who work at our London headquarters.

If you are attending EULAR 2014, we would love to meet with you. Please stop by our presentation at Poster area A, Level 1 between 11:45 - 13:30, when we will be sharing new insights gleaned from our Therapy Watch database into the clinical drivers behind current treatment strategies and the use of biologic monotherapy among rheumatoid arthritis patients. Alternatively, please contact us now and we will arrange a suitable time to talk. Our Directors will be happy to answer any questions you may have about our abstracts or our Therapy Watch offering. We have made exciting new developments to our real-time patient tracking tool and have recently added a number of new therapy areas and territories to the portfolio.

About our abstracts:

Poster presentation FRI0068
Friday 13th June, 11:45-13:30
Use of Biologic Monotherapy among Rheumatoid Arthritis Patients: Investigating Clinical Drivers for Treatment Choice
Written by Laurent Chanroux Associate Director of Therapy Watch, the poster uses data collected as part of our Therapy Watch patient tracking survey conducted amongst a panel of 240 rheumatologists between January and December 2013 across the 5 main EU markets and a logistic regression analysis using a sub-sample of 5,200 patient records.

Abstract ABO383
Long-Term Biologic Drugs Survival in Rheumatoid Arthritis Patients: A Study Based on Observational RA Data from the Research Partnership
Written by Dr G. Carlino, the abstract is based on an analysis of 25,293 patient records collected as part of the Therapy Watch patient tracking survey in 2013.

Please contact us now to arrange a suitable time to talk to our Directors at EULAR.

For more information on EULAR Congress 2014, please go to

Sign up to receive Rapport 
Rapport is our e-newsletter and online resource for sharing our expertise and experience in global healthcare market research. Sign up here » 


comments powered by Disqus